Transport properties of pancreatic cancer describe gemcitabine delivery and response

Pancreatic Cancer

Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195

Pancreatic cancer

Li, D., Xie, K., Wolff, R. A., & Abbruzzese, J. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15841-8 · Cited by 1,731

CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,706

Intravenous Contrast Medium Administration and Scan Timing at CT: Considerations and Approaches

Bae, K. T. (2010) · Radiology · doi:10.1148/radiol.10090908 · Cited by 1,068

Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

Stylianopoulos, T., Martin, J. D., Chauhan, V. P., Jain, S. R., Diop-Frimpong, B., Bardeesy, N., Smith, B. L., Ferrone, C. R., Hornicek, F. J., Boucher, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213353109 · Cited by 943

Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

Varadhachary, G. R., Tamm, E. P., Abbruzzese, J. L., Xiong, H. Q., Crane, C. H., Wang, H., Lee, J. E., Pisters, P. W. T., Evans, D. B., & Wolff, R. A. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.08.011 · Cited by 876

Transport of molecules across tumor vasculature

Jain, R. K. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00047468 · Cited by 869

Stromal biology and therapy in pancreatic cancer

Neeße, A., Michl, P., Frese, K. K., Feig, C., Cook, N., Jacobetz, M. A., Lolkema, M. P., Buchholz, M., Olive, K. P., Gress, T. M., et al. (2010) · Gut · doi:10.1136/gut.2010.226092 · Cited by 780

Analysis of nanoparticle delivery to tumours

Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218

Early Detection of Pancreatic Cancer: Opportunities and Challenges

Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841

Transport of drugs from blood vessels to tumour tissue

Dewhirst, M. W., & Secomb, T. W. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.93 · Cited by 749

Stromal biology and therapy in pancreatic cancer: a changing paradigm

Neeße, A., Algül, H., Tuveson, D. A., & Gress, T. M. (2015) · Gut · doi:10.1136/gutjnl-2015-309304 · Cited by 567

Early detection of pancreatic cancer

Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482

Pancreatic Cancer Chemoresistance to Gemcitabine

Amrutkar, M., & Gladhaug, I. P. (2017) · Cancers · doi:10.3390/cancers9110157 · Cited by 467

Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer

Halbrook, C. J., Pontious, C., Kovalenko, I., Lapienyte, L., Dreyer, S., Lee, H.-J., Thurston, G., Zhang, Y., Lazarus, J., Sajjakulnukit, P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.001 · Cited by 419

Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics

Dogra, P., Adolphi, N. L., Wang, Z., Lin, Y., Butler, K. S., Durfee, P. N., Croissant, J. G., Noureddine, A., Coker, E. N., Bearer, E. L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06730-z · Cited by 263

Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer

Adiseshaiah, P. P., Crist, R. M., Hook, S. S., & McNeil, S. E. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.119 · Cited by 239

Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer

Heßmann, E., Patzak, M. S., Klein, L., Chen, N., Kari, V., Ramu, I., Bapiro, T. E., Frese, K. K., Gopinathan, A., Richards, F. M., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311954 · Cited by 205

The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer

Sun, Q., Zhang, B., Hu, Q., Qin, Y., Xu, W., Liu, W., Yu, X., & Xu, J. (2018) · Theranostics · doi:10.7150/thno.26546 · Cited by 201

STAT3 Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer

Nagathihalli, N. S., Castellanos, J. A., Shi, C.-J., Beesetty, Y., Reyzer, M. L., Caprioli, R., Chen, X., Walsh, A., Skala, M., Moses, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.058 · Cited by 178

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Katz, M. H. G., Ou, F., Herman, J. M., Ahmad, S. A., Wolpin, B. W., Marsh, R., Behr, S. C., Shi, Q., Chuong, M. D., Schwartz, L. H., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3441-z · Cited by 188

Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

Ramanathan, R. K., Korn, R. L., Raghunand, N., Sachdev, J. C., Newbold, R. G., Jameson, G., Fetterly, G. J., Prey, J., Klinz, S. G., Kim, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1990 · Cited by 183

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going

Liang, C., Shi, S., Meng, Q., Liang, D., Ji, S., Zhang, B., Qin, Y., Xu, J., Ni, Q., & Yu, X. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.255 · Cited by 166

Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer

Tang, C., Hobbs, B., Amer, A., Li, X., Behrens, C., Canales, J. R., Cuentas, E. P., Villalobos, P., Fried, D., Chang, J. Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20471-5 · Cited by 154

Mathematical modeling in cancer nanomedicine: a review

Dogra, P., Butner, J. D., Chuang, Y.-L., Caserta, S., Goel, S., Brinker, C. J., Vittorio Cristini, C., & Wang, Z. (2019) · Biomedical Microdevices · doi:10.1007/s10544-019-0380-2 · Cited by 154

Quantitative imaging to evaluate malignant potential of IPMNs

Hanania, A. N., Bantis, L. E., Feng, Z., Wang, H., Tamm, E. P., Katz, M. H., Maitra, A., & Koay, E. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11769 · Cited by 143

Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?

Huang, Y., Lin, D., & Taniguchi, C. M. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9178-y · Cited by 150

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature

Gilles, M.-E., Maione, F., Cossutta, M., Carpentier, G., Caruana, L., Maria, S. D., Houppe, C., Destouches, D., Shchors, K., Prochasson, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0300 · Cited by 138

Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer

Fan, J., Wei, Q., Koay, E. J., Liu, Y., Ning, B., Bernard, P. W., Zhang, N., Han, H., Katz, M. H. G., Zhao, Z., et al. (2018) · Theranostics · doi:10.7150/thno.26650 · Cited by 139

Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation

Ju, H.-Q., Gocho, T., Aguilar, M., Wu, M., Zhuang, Z.-N., Fu, J., Yanaga, K., Huang, P., & Chiao, P. J. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0420 · Cited by 137

Matrix control of pancreatic cancer: New insights into fibronectin signaling

Topalovski, M., & Brekken, R. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.027 · Cited by 137

ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells

Liu, M., Zhang, Y., Yang, J., Cui, X., Zhou, Z., Zhan, H., Ding, K., Tian, X., Yang, Z., Fung, K.-M. A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.10.038 · Cited by 132

Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma

Chang, J. C. S., & Kundranda, M. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030667 · Cited by 127

Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape

Olaussen, K. A., & Postel-Vinay, S. C. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw321 · Cited by 124

Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence

Franco-Barraza, J., Francescone, R., Luong, T., Shah, N., Madhani, R., Cukierman, G., Dulaimi, E., Devarajan, K., Egleston, B. L., Nicolas, E., et al. (2017) · eLife · doi:10.7554/elife.20600 · Cited by 112

A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma

Koay, E. J., Lee, Y., Cristini, V., Lowengrub, J. S., Kang, Y., Lucas, F. A. S., Hobbs, B. P., Ye, R., Elganainy, D., Almahariq, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3668 · Cited by 110

Tissue Transglutaminase Mediated Tumor–Stroma Interaction Promotes Pancreatic Cancer Progression

Lee, J., Condello, S., Yakubov, B., Emerson, R. E., Caperell–Grant, A., Hitomi, K., Xie, J., & Matei, D. E. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0226 · Cited by 93

Fasting cycles potentiate the efficacy of gemcitabine treatment inin vitroandin vivopancreatic cancer models

D’Aronzo, M., Vinciguerra, M., Mazza, T., Panebianco, C., Saracino, C., Pereira, S. P., Graziano, P., & Pazienza, V. (2015) · Oncotarget · doi:10.18632/oncotarget.4186 · Cited by 87

Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients

Chakraborty, J., Langdon-Embry, L., Cunanan, K. M., Escalon, J. G., Allen, P. J., Lowery, M. A., O’Reilly, E. M., Gönen, M., Do, R. G., & Simpson, A. L. (2017) · PLOS ONE · doi:10.1371/journal.pone.0188022 · Cited by 85

Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway

Lee, J., Kim, D., & Kim, J. H. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.11.022 · Cited by 84

Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases

Tanei, T., Leonard, F., Liu, X., Alexander, J. F., Saito, Y., Mauro Ferrari, B., Godin, B., & Yokoi, K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1576 · Cited by 78

Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer

Heid, I., Steiger, K., Trajkovic‐Arsic, M., Settles, M., Eßwein, M. R., Erkan, M., Kleeff, J. H., Jäger, C., Friess, H., Haller, B., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2432 · Cited by 78

Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells

Affram, K., Smith, T., Ofori, E., Krishnan, S., Underwood, P. W., Trevino, J. G., & Agyare, E. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101374 · Cited by 75

Tumor vascular permeabilization using localized mild hyperthermia to improve macromolecule transport

Kirui, D. K., Koay, E. J., Guo, X., Vittorio Cristini, C., Shen, H., & Mauro Ferrari, B. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.11.001 · Cited by 75

EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer

Levy, M. J., Alberts, S. R., Bamlet, W. R., Burch, P. A., Farnell, M. B., Gleeson, F. C., Haddock, M. G., Kendrick, M. L., Oberg, A. L., Petersen, G. M., et al. (2016) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2016.11.014 · Cited by 74

Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway

Namba, T., Kodama, R., Moritomo, S., Hoshino, T., & Mizushima, T. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.172 · Cited by 73

Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer

Yang, J., Xu, J., Zhang, B., Tan, Z., Meng, Q., Hua, J., Liu, J., Wang, W., Shi, S., Yu, X., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010944 · Cited by 69

Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment

de Maar, J. S., Sofias, A. M., Porta Siegel, T., Vreeken, R. J., Moonen, C., Bos, C., & Deckers, R. (2020) · Theranostics · doi:10.7150/thno.38625 · Cited by 71

Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor‐κ B activation

Ju, H., Li, H., Tian, T., Lu, Y., Bai, L., Chen, L.-Z., Sheng, H., Mo, H., Zeng, J., Deng, W., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12285 · Cited by 66

Integrated PK-PD and agent-based modeling in oncology

Wang, Z., Butner, J. D., Vittorio Cristini, C., & Deisboeck, T. S. (2015) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-015-9403-7 · Cited by 69

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

Hosoya, H., Dobroff, A. S., Driessen, W. H. P., Vittorio Cristini, C., Brinker, L. M., Staquicini, F. I., Cardó‐Vila, M., D’Angelo, S., Ferrara, F., Proneth, B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525796113 · Cited by 66

A comprehensive review of 3D cancer models for drug screening and translational research

Sharma, K., Dey, S., Karmakar, R., & Rengan, A. K. (2023) · Cancer Innovation · doi:10.1002/cai2.102 · Cited by 60

MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma

Dhayat, S. A., Mardin, W. A., Seggewiß, J., Ströse, A., Matuszcak, C., Hummel, R., Senninger, N. J., Mees, S. T., & Haier, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143755 · Cited by 59

Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill

Wang, Z., Kerketta, R., Chuang, Y.-L., Dogra, P., Butner, J. D., Brocato, T. A., Day, A., Xu, R., Shen, H., Simbawa, E. A., et al. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004969 · Cited by 57

Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy

Butner, J. D., Elganainy, D., Wang, C. X., Wang, Z., Chen, S., Esnaola, N. F., Pasqualini, R., Arap, W., Hong, D. S., Welsh, J. W., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay6298 · Cited by 53

Understanding the Connection between Nanoparticle Uptake and Cancer Treatment Efficacy using Mathematical Modeling

Brocato, T. A., Coker, E. N., Durfee, P. N., Lin, Y., Townson, J. L., Wyckoff, E. F., Vittorio Cristini, C., Brinker, C. J., & Wang, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-25878-8 · Cited by 56

Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma

Katsoulakis, E., Yu, Y., Apte, A., Leeman, J. E., Katabi, N., Morris, L. G. T., Deasy, J. O., Chan, T. A.-T., Lee, N. Y., Riaz, N., et al. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104877 · Cited by 58

Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN.

Xia, X., Zhang, K., Luo, G., Cen, G., Cao, J., Huang, K., & Qiu, Z. (2017) · PubMed Central · Cited by 52

ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer

Görür, A., Bayraktar, R., Ivan, C., Mokhlis, H. A., Bayraktar, E., Kahraman, N., Karakaş, D., Karamil, S., Kabil, N. N., Kanlikilicer, P., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.01.016 · Cited by 52

Quercetin-3-O-glucoside suppresses pancreatic cancer cell migration induced by tumor-deteriorated growth factors in vitro

Lee, J., Lee, J., Kim, S. J., & Kim, J. H. (2016) · Oncology Reports · doi:10.3892/or.2016.4598 · Cited by 49

Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery

Søreide, K., Ismail, W., Roalsø, M. T. T., Ghotbi, J., & Zaharia, C. (2023) · Cancer Control · doi:10.1177/10732748231154711 · Cited by 48

Pancreatic cancer and FOLFIRINOX : a new era and new questions

Marsh, R., Talamonti, M., Katz, M. H. G., & Herman, J. M. (2015) · Cancer Medicine · doi:10.1002/cam4.433 · Cited by 44

The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival

Delitto, D., Black, B. S., Sorenson, H. L., Knowlton, A. E., Thomas, R. M., Sarosi, G. A., Moldawer, L. L., Behrns, K. E., Liu, C., George, T. J., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1820-x · Cited by 44

Imaging-based biomarkers: changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy

Amer, A. M., Zaid, M., Chaudhury, B., Elganainy, D., Lee, Y., Wilke, C. T., Cloyd, J., Wang, H., Maitra, A., Wolff, R. A., et al. (2018) · Cancer · doi:10.1002/cncr.31251 · Cited by 43

Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling

Wang, B., Shen, C., Li, Y., Zhang, T., Huang, H., Ren, J., Hu, Z., Xu, J., & Xu, B. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s208924 · Cited by 43

A mathematical model for the quantification of a patient’s sensitivity to checkpoint inhibitors and long-term tumour burden

Butner, J. D., Wang, Z., Elganainy, D., Feghali, K. A. A., Plodinec, M., Călin, G. A., Dogra, P., Nizzero, S., Ruiz-Ramírez, J., Martin, G. V., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00662-0 · Cited by 43

Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation

Healy, G. M., Salinas-Miranda, E., Jain, R., Dong, X., Deniffel, D., Borgida, A., Hosni, A., Ryan, D. T., Njeze, N., McGuire, A., et al. (2021) · European Radiology · doi:10.1007/s00330-021-08314-w · Cited by 43

Isolation of pancreatic cancer cells from a patient-derived xenograft model allows for practical expansion and preserved heterogeneity in culture

Pham, K., Delitto, D., Knowlton, A. E., Hartlage, E. R., Madhavan, R., Gonzalo, D. H., Thomas, R. M., Behrns, K. E., George, T. J., Hughes, S. J., et al. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.02.009 · Cited by 46

Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming

Li, T., Tong, H., Yin, H., Luo, Y., Zhu, J., Qin, Z., Yin, S., & He, W. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02303-1 · Cited by 40

Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates

De Lellis, L., Veschi, S., Tinari, N., Mokini, Z., Carradori, S., Brocco, D., Florio, R., Grassadonia, A., & Cama, A. (2021) · Cancers · doi:10.3390/cancers13163946 · Cited by 40

Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?

Liang, C., Shi, S., Meng, Q., Liang, D., Ji, S., Zhang, B., Qin, Y., Xu, J., Ni, Q., & Yu, X. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2678-7 · Cited by 39

Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy

Gregucci, F., Fiorentino, A., Mazzola, R., Ricchetti, F., Bonaparte, I., Surgo, A., Figlia, V., Carbonara, R., Caliandro, M., Ciliberti, M. P., et al. (2022) · La radiologia medica · doi:10.1007/s11547-021-01422-z · Cited by 38

Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer

Koay, E. J., Baio, F. E., Ondari, A., Truty, M. J., Vittorio Cristini, C., Thomas, R. M., Chen, R., Chatterjee, D., Kang, Y., Zhang, J., et al. (2014) · Physical Biology · doi:10.1088/1478-3975/11/6/065002 · Cited by 38

CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma

Maity, G., Ghosh, A., Gupta, V. G., Haque, I., Sarkar, S., Das, A. K., Dhar, K., Bhavanasi, S., Gunewardena, S., Hoff, D. D. V., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0899 · Cited by 38

Understanding Drug Resistance in Breast Cancer with Mathematical Oncology

Brocato, T. A., Dogra, P., Koay, E. J., Day, A., Chuang, Y.-L., Wang, Z., & Vittorio Cristini, C. (2014) · Current Breast Cancer Reports · doi:10.1007/s12609-014-0143-2 · Cited by 34

Nicotine Reduces Survival via Augmentation of Paracrine HGF–MET Signaling in the Pancreatic Cancer Microenvironment

Delitto, D., Zhang, D., Han, S., Black, B. S., Knowlton, A. E., Vlada, A. C., Sarosi, G. A., Behrns, K. E., Thomas, R. M., Lu, X., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1256 · Cited by 36

Targeting tumor tolerance: A new hope for pancreatic cancer therapy?

Delitto, D., Wallet, S. M., & Hughes, S. J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.008 · Cited by 37

Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC

Colbert, L. E., Moningi, S., Chadha, A. S., Amer, A. M., Lee, Y., Wolff, R. A., Varadhachary, G. R., Fleming, J. B., Katz, M. H. G., Das, P., et al. (2017) · Advances in Radiation Oncology · doi:10.1016/j.adro.2017.02.004 · Cited by 34

Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells

Lee, J., Yun, J. H., Lee, J., Choi, C., & Kim, J. H. (2015) · Scientific Reports · doi:10.1038/srep12296 · Cited by 33

Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A

Lee, J., Lee, J., Yun, J. H., Choi, C., Cho, S., Kim, S. J., & Kim, J. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-13023-w · Cited by 34

An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms

Yao, H.-J., Song, W., Cao, R., Ye, C., Zhang, L., Chen, H., Wang, J., Shi, Y., Li, R. P., Li, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33037-x · Cited by 34

90 Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies

Picozzi, V. J., Ramanathan, R. K., Lowery, M. A., Ocean, A. J., Mitchel, E. P., O’Neil, B. H., Guarino, M. J., Conkling, P., Cohen, S. J., Bahary, N., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.119 · Cited by 32

Dynamic Targeting in Cancer Treatment

Wang, Z., & Deisboeck, T. S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00096 · Cited by 29

Diffusion-weighted MRI predicts the histologic response for neoadjuvant therapy in patients with pancreatic cancer: a prospective study (DIFFERENT trial)

Okada, K., Kawai, M., Hirono, S., Kojima, F., Tanioka, K., Terada, M., Miyazawa, M., Kitahata, Y., Iwahashi, Y., Ueno, M., et al. (2020) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-020-01857-4 · Cited by 30

Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer

Amrutkar, M., & Gladhaug, I. P. (2021) · Cancers · doi:10.3390/cancers13040601 · Cited by 31

Fermented Extraction of Citrus unshiu Peel Inhibits Viability and Migration of Human Pancreatic Cancers

Lee, J., Lee, J., Kim, M., & Kim, J. H. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.3984 · Cited by 30

Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer

Koay, E. J., Katz, M. H. G., Wang, H., Wang, X., Prakash, L., Javle, M. M., Shroff, R. T., Fogelman, D. R., Avila, S., Zaid, M., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00001 · Cited by 29

Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells

Bjånes, T. K., Kotopoulis, S., Murvold, E. T., Kamčeva, T., Gjertsen, B. T., Gilja, O. H., Schjøtt, J. D., Riedel, B., & McCormack, E. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020141 · Cited by 29

Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers

Koay, E. J., Amer, A. M., Baio, F. E., Ondari, A., & Fleming, J. B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.006 · Cited by 27

Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies

Wolff, R. A. (2017) · Surgical Clinics of North America · doi:10.1016/j.suc.2017.09.009 · Cited by 27

Digital twinning of Cellular Capsule Technology: Emerging outcomes from the perspective of porous media mechanics

Urcun, S., Rohan, P., Skalli, W., Nassoy, P., Bordas, S., & Sciumè, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254512 · Cited by 31

A nano-enabled cancer-specific ITCH RNAi chemotherapy booster for pancreatic cancer

de la Fuente, M., Jones, M., Santander-Ortega, M. J., Mirenska, A., Marimuthu, P., Uchegbu, I. F., & Schätzlein, A. G. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.010 · Cited by 27

Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine

Grixti, J. M., O’Hagan, S., Day, P. J., & Kell, D. B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00155 · Cited by 27

Stroma — A Double-Edged Sword in Pancreatic Cancer

Gu, J., Saiyin, H., Fu, D., & Li, J. (2018) · Pancreas · doi:10.1097/mpa.0000000000001023 · Cited by 24

Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancreatic cancer

Ge, J., & Ge, C. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2455-5 · Cited by 24

Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine

Forciniti, S., Pozza, E. D., Greco, M. R., Carvalho, T. M. A., Rolando, B., Ambrosini, G., Carmona‐Carmona, C. A., Pacchiana, R., Molfetta, D. D., Donadelli, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010029 · Cited by 26

A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases

Anaya, D. A., Dogra, P., Wang, Z., Haider, M., Ehab, J., Jeong, D. K., Ghayouri, M., Lauwers, G. Y., Thomas, K., Kim, R. D., et al. (2021) · Cancers · doi:10.3390/cancers13030444 · Cited by 24

Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression

Moravec, R., Divi, R. L., & Verma, M. (2017) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v9.i6.235 · Cited by 24

Pancreatic cancer detection and characterization—state of the art cross-sectional imaging and imaging data analysis

Kaissis, G. A., & Braren, R. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.05.04 · Cited by 24

Correction function for accuracy improvement of the Composite Smeared Finite Element for diffusive transport in biological tissue systems

Milošević, M., Simić, V., Miličević, B., Koay, E. J., Mauro Ferrari, B., Žiemys, A., & Kojić, M. (2018) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2018.04.012 · Cited by 23

Predictive Modeling of Drug Response in Non-Hodgkin’s Lymphoma

Frieboes, H. B., Smith, B. R., Wang, Z., Kotsuma, M., Ito, K., Day, A., Cahill, B., Flinders, C., Mumenthaler, S. M., Mallick, P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129433 · Cited by 22

Mathematical Modeling to Address Challenges in Pancreatic Cancer

Dogra, P., Ruiz-Ramírez, J., Peláez, M. J., Wang, Z., Vittorio Cristini, C., Parasher, G., & Rawat, M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200101095641 · Cited by 20

Molecular mechanisms of microRNA-301a during tumor progression and metastasis

Shad, A. N., Fanoodi, A., Maharati, A., Akhlaghipour, I., & Moghbeli, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154538 · Cited by 20

Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study

Zaid, M., Widmann, L., Dai, A., Sun, K., Zhang, J., Zhao, J., Hurd, M. W., Varadhachary, G. R., Wolff, R. A., Maitra, A., et al. (2020) · Cancers · doi:10.3390/cancers12123656 · Cited by 19

Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies

du Toit‐Thompson, T., Leck, L. Y. W., Gillson, J., Pavlakis, N., Gill, A. J., Samra, J. S., Mittal, A., & Sahni, S. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115647 · Cited by 20

Predicting breast cancer response to neoadjuvant chemotherapy based on tumor vascular features in needle biopsies

Brocato, T. A., Brown-Glaberman, U. A., Wang, Z., Selwyn, R. G., Wilson, C. M., Wyckoff, E. F., Lomo, L. C., Saline, J. L., Hooda-Nehra, A., Pasqualini, R., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126518 · Cited by 18

Pancreatic Tumor Transport Properties Affect Gemcitabine Uptake and Efficacy

(2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2014-071

Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer

Koay, E. J., Baio, F. E., Ondari, A., Truty, M. J., Vittorio Cristini, C., Thomas, R. M., Chen, R., Chatterjee, D., Kang, Y., Zhang, J., et al. (2014) · Physical Biology · doi:10.1088/1478-3975/11/6/065002 · Cited by 38

Application of Cancer Physics in the Clinic

(2017) · Chapman & Hall/CRC eBooks · doi:10.4324/9781315374499-7

Stromal and epithelial mechanisms of chemotherapeutic resistance in pancreatic cancer

Patzak, M. S. (2019) · doi:10.53846/goediss-7441

Drug delivery in pancreatic cancer : Quantitative studies of gemcitabine and sonoporation in patients and cell line models

Bjånes, T. K. (2020) · NORA - Norwegian Open Research Archives